A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation

Clinical trial NCT00668759 · COMPLETED

Trial details

NCT number: NCT00668759
Sponsor: Advanz Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2008-04-01
Primary completion: 2009-10-01
Enrollment: 254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.